baber/WOPTO huggingface dataset:
Patent JP-2001522374-A (JP)
Title: ドパミンｄ３受容体モジュレーターとしての置換テトラヒドロイソキノリン類
IPC: A61K31/472
Filed: 1998-04-27
Abstract: (57)【要約】
式（Ｉ）：
 ［式中、Ｒ 1 は、水素またはハロゲン原子；ヒドロキシ、シアノ、ニトロ、トリフルオロメチル、トリフルオロメトキシ、トリフルオロメタンスルホニルオキシ、ペンタフルオロエチル、Ｃ 1-4 アルキル、Ｃ 1-4 アルコキシ、アリールＣ 1-4 アルコキシ、Ｃ 1-4 アルキルチオ、Ｃ 1-4 アルコキシＣ 1-4 アルキル、Ｃ 3-6 シクロアルキルＣ 1-4 アルコキシ、Ｃ 1-4 アルカノイル、Ｃ 1-4 アルコキシカルボニル、Ｃ 1-4 アルキルスルホニル、Ｃ 1-4 アルキルスルホニルオキシ、Ｃ 1-4 アルキルスルホニルＣ 1-4 アルキル、アリールスルホニル、アリールスルホニルオキシ、アリールスルホニルＣ 1-4 アルキル、Ｃ 1-4 アルキルスルホンアミド、Ｃ 1-4 アルキルアミド、Ｃ 1-4 アルキルスルホンアミドＣ 1-4 アルキル、Ｃ 1-4 アルキルアミドＣ 1-4 アルキル、アリールスルホンアミド、アリールカルボキシアミド、アリールスルホンアミドＣ 1-4 アルキル、アリールカルボキシアミドＣ 1-4 アルキル、アロイル、アロイルＣ 1-4 アルキル、またはアリールＣ 1-4 アルカノイル基；基Ｒ 3 ＯＣＯ(ＣＨ 2 ) p 、Ｒ 3 ＣＯＮ(Ｒ 4 )(ＣＨ 2 ) p 、Ｒ 3 Ｒ 4 ＮＣＯ(ＣＨ 2 ) p またはＲ 3 Ｒ 4 ＮＳＯ 2 (ＣＨ 2 ) p (ここにＲ 3 およびＲ 4 はそれぞれ独立して水素原子またはＣ 1-4 アルキル基であるか、あるいはＲ 3 Ｒ 4 はＣ 3-6 アザシクロアルカンまたはＣ 3-6 (２−オキソ)アザシクロアルカン環の一部を形成し、ｐはゼロまたは１ないし４の整数である)；または基Ａｒ 3 −Ｚ（ここにＡｒ 3 は置換されていてもよいフェニル環または置換されていてもよい５もしくは６員の香族複素環であり、Ｚは結合、Ｏ、ＳまたはＣＨ 2 である）から選択される置換基であり；Ｒ 2 は水素原子またはＣ 1-4 アルキル基であり；Ｘは式（ａ）または（ｂ）：
   （式中、ＡｒおよびＡｒ 1 はそれぞれ独立して、置換されていてもよいフェニル環または置換されていてもよい５もしくは６員の芳香族複素環である）で示される基であり；Ｙは結合、−ＮＨＣＯ−、−ＣＯＮＨ−、−ＣＨ 2 −または−(ＣＨ 2 ) m Ｙ 1 (ＣＨ 2 ) n −であり、ここにＹ 1 はＯ、Ｓ、ＳＯ 2 またはＣＯであり、ｍおよびｎはそれぞれ、ｍとｎとの和がゼロまたは１となるようにゼロまたは１であり；Ａｒ 2 は置換されていてもよいフェニル環または置換されていてもよい５もしくは６員の芳香族複素環であるか、あるいは置換されていてもよい二環式の環システムである］で示される化合物およびその塩。式（Ｉ）の化合物およびそれらの塩はドパミン受容体、特にＤ 3 受容体に対して親和性を有し、それゆえ、Ｄ 3 受容体の転調が有益である症状の治療において、例えば抗精神病薬として、潜在能力を有する。
Patent JP-2002505827-A (JP)
Title: 符号クロス積自動周波数制御ループ
IPC: H03L7/06
Filed: 1999-03-17
Abstract: (57)【要約】
受信器の周波数を送信器の周波数と整合させるための複雑さの少ない自動周波数制御（ＡＦＣ）ループである。受信された入力信号は、電圧制御発振器の正弦信号及び余弦信号によって乗算され、ディジタル化及びフィルタリングされ、受信された入力信号の余弦関数の符号（最上位ビット）は２つの符号ゲートへの入力を与えるよう符号スライサ回路によって切り出される。２つの符号ゲートの出力は、受信された信号の周波数を整合させるよう電圧制御発振器を制御するのに使用される周波数誤差の推定値を発生するために加算される。ＡＦＣループを実施するのに必要とされる乗算器回路の所望とされる数は、符号スライサ回路の使用及び符号ゲートを使用することにより従来技術のＡＦＣループよりも減少される。
Patent JP-2000513289-A (JP)
Title: 有機／無機混合層を有する構造体でのリソグラフ印刷用イメージング
IPC: B41N1/14
Filed: 1999-03-17
Abstract: (57)【要約】
リソグラフ印刷部材の有機層と無機層の間の界面遷移の影響が、有機層のマトリクス中に無機成分を取り入れることによって軽減される。第１の側面では、隣接する有機層と無機層を有するリソグラフ印刷プレートが、硬化可能なポリマーを堆積し、このポリマーを軟化させ、これに無機材料を一体化させることによって製造される。このポリマーは次いで硬化されて、一体化された堆積材料を固定化し、所望の無機層がこの堆積された無機材料（及びポリマーの露出部分）を覆って適用される。第２の側面では、順次の堆積工程において、段階的構造体が基体上に構築される。ポリマー前駆体と無機充填材の両者が各段において堆積され、各段においてポリマーと充填材は所望の比率で含有される。
Patent JP-2002511208-A (JP)
Title: マルチステーション映像／音声配給装置
IPC: H04H60/04
Filed: 1998-03-25
Abstract: (57)【要約】
マルチステーション映像／音声配給装置は、少なくとも二つのプレビューステーションと、データコントロール機構と、プレビューステーションとデータコントロール機構の間に配置されたプレビューステーション・インターフェース機構と、プレビューステーションとデータコントロール機構の間に配置された映像ディスプレー・インターフェース機構とを有している。各プレビューステーションは、映像素材選択を入力するためのバーコードスキャナーの形態のユーザー入力と、音声出力と、映像ディスプレーとを有している。データコントロール機構は、ユーザーによるビデオ素材選択に各々に対応するデジタル化された映像及び音声データを取り出す。プレビューステーション・インターフェース機構は、ユーザーの入力を各プレビューステーションからデータコントロール機構に転送し、ユーザーの入力に対応するデジタル化された音声素材をデータコントロール機構から受信し、そのデジタル音声素材をアナログ音声信号に変換し、そのアナログ音声信号を、音声出力のための対応するプレビューステーションに転送する。映像ディスプレー・インターフェース機構は、データコントロール機構からのユーザー入力の各々に対応するデジタル化された映像素材を受信し、そのデジタル映像素材を映像ディスプレーに受け入れ可能な形式に変換し、形式変換された映像素材を映像ディスプレーに転送する。
Patent MX-159352-A (MX)
Inventor: DUMORA DENIS
IPC: H01B17/40
Filed: 1984-02-21
Abstract: The present invention provides a method of fixing a sleeve (3) of malleable metal on a rod (10) of composite material, said sleeve comprising a cylindrical internal housing (6) in which an end (11) of said rod (10) is received. A compression operation is performed causing the sleeve to be stretched in a continuous manner over annular zones of the sleeve substantially from the inlet of the sleeve and substantially up to the end of the rod in such a manner as to cold draw the metal of the sleeve around the rod without stretching the composite material beyond its elastic strain limit.
Patent MX-157990-A (MX)
Inventor: MORRIS ROBERT ALLAN
IPC: H01H71/12
Filed: 1985-02-13
Abstract: A ground fault circuit interrupter interconnect arrangement provides wireless connection with line and neutral main current terminals by insertion through an aperture in the interrupter magnetic sensor module to form a magnetic sensor plug-in subassembly. The electronics components and trip solenoid are mounted to the interrupter printed wire board. The magnetic sensor subassembly is plugged into the printed wire board for interconnection with the electronics components. This allows the interrupter to be assembled in a completely automated process.
Patent NZ-198721-A (NZ)
Title: Moulding toric contact lenses:axes of mould halves at an angle to each other
Inventor: NOBLE E
IPC: B29D11/00
Filed: 1981-10-21
Abstract: Molded toric contacted lenses which exhibit cylinder power and prism ballast are manufactured in a mold assembly comprised of a female mold portion having a cylindrical support segment (12) and a concave toric optical molding surface (16) set internally therein and a male mold portion (2) having a cylindrical support segment (7) and a convex optical molding surface (10) at one end thereof. Contact lens-form material is charged on to molding surface (16) and the mold assembly is closed by positioning male mold portion (2) in touching and lens-forming relationship with female mold portion to form the angle  theta  between the two principal axes of curvature of the said molding surfaces. Polymerization of the lens-forming material results in a molded toric contact lens.
Patent NZ-214086-A (NZ)
Title: Method and dough composition for making shelf-stable soft or chewy cookies
Inventor: THULIN R R
IPC: A21D13/08
Filed: 1985-11-05
Abstract: Cookies having an extended shelf-stable soft or chewy texture throughout the cookie are prepared by coextruding an inner adherent cookie dough bakeable to a soft or chewy texture and an outer non-adherent cookie dough bakeable to a soft or chewy texture. The inner dough comprises a liquid humectant in an amount sufficient to impart a shelf-stable soft or chewy texture to the baked outer cookie dough in excess of that attainable by baking the outer dough alone to a shelf-stable soft or chewy texture of the same moisture content. The coextrudate is severed into pieces to enrobe the inner cookie dough and the pieces are baked to a moisture content of at least about 6% by weight of the cookie. The outer non-adherent cookie dough, while being bakeable to a soft chewy texture, possesses sufficient cohesiveness and firmness so as to render the coextrudate formable into cookie dough pieces on a mass scale. The use of the non-adherent cookie dough to enrobe the adherent filler dough avoids sticking of the inner adherent cookie dough to oven bands and cookie dough cutting equipment.
Patent NZ-214909-A (NZ)
Title: Supplying hot solid particles to retorting vessel
Inventor: EVERTS R
IPC: B01J4/00
Filed: 1986-01-23
Abstract: The invention relates to an apparatus (50) for the supply of hot solid particles, preferably hot spent substrate particles, to a retorting vessel (46) for the extraction of hydrocarbons from a hydrocarbon-containing substrate. The apparatus comprises a slide (52) arranged at an angle (for example at an angle of 5 DEG  to 10 DEG ) to the horizontal plane, said slide (52) having a bottom and fluidization means in or close to the bottom, means for the supply of fluidization gas to the fluidization means of the slide, one or more draw-off vessels (53, 54, 55, 56, 57) below the slide (52), which draw-off vessels (53, 54, 55, 56, 57) are in communication with the slide (52) and with corresponding inlets (41, 42, 43, 44, 45) for hot solid particles of the retorting vessel (46). Fluidization means are present in each draw-off vessel and furthermore means for the supply of fluidization gas to the fluidization means of each draw-off vessel (53, 54, 55, 56, 57) are present. 
<??>The invention relates as well to a method for the supply of hot solid particles to a retorting vessel by means of the apparatus according to the invention.
Patent NZ-224549-A (NZ)
Title: Controlled release polymer microspheres containing at least one active agent
Inventor: TRAU MATT
IPC: A61K9/50
Filed: 1988-05-09
Abstract: Controlled release microspheres of hydroxybutyrate polymer comprise active ingredient and hydroxybutyrate/hydroxyvalerate copolymer. The microspheres comprise a skin which is distinct from the general bulk of the microspheres, and this skin may have a porosity covering from 0-50% of the total surface area of the microsphere, this porosity being largely controlled by varying the hydroxyvalerate content of the polymer. The porosity of the interior of the microspheres can also be regulated. Control of the two porosities permits the attainment of a wide range of release rates for a wide range of active ingredients. The microspheres can be used in a wide variety of pharmaceutical, veterinary and agricultural applications.
Patent NZ-226201-A (NZ)
Title: 1-(benzylpiperidino)propan-2-ol derivatives and use as antiseptics, disinfectants or preservatives
Inventor: VAN BROECK DIDIER
IPC: C07D211/14
Filed: 1988-09-15
Abstract: Compounds of formula: 
<IMAGE>
 in which:
 - Ar denotes a phenyl group substituted by R2, R3 and R4 or a 1-naphthyl or 2-naphthyl group, unsubstituted or substituted by 1 or 2 halogen atoms;
 - X denotes an oxygen atom or a sulphur atom;
 - R1 denotes H or a halogen atom;
 - R2 denotes a halogen atom, a trifluoromethyl group, a phenyl group unsubstituted or substituted by 1 to 3 halogen atoms, a benzyl group unsubstituted or substituted by 1 to 3 halogen atoms, a phenoxy group unsubstituted or substituted by 1 to 3 halogen atoms or a C1-C4 alkyl group;
 - R3 and R4 denote H, a halogen atom or a C1-C4 alkyl group;
 - the benzyl group substitutes the piperidino radical in position 2, 3 or 4;
 and their salts with inorganic or organic acids. 
<??>The invention also relates to a process for the preparation of the said compounds and to their use as antimicrobial agents, as antiseptics, disinfectants, stabilisers in various types of products (pharmaceutical compositions, cosmetic products, alimentary products etc.). It also relates to the said products containing the compounds of formula (I).
Patent NZ-230344-A (NZ)
Title: N-sulphomethylglycinates and preparation thereof
Inventor: BOTANNET BERNARD
IPC: C07C309/14
Filed: 1989-08-17
Abstract: The invention relates to an N-sulfomethylglycinate of formula: HO3S-CH2-NH-CH2-COOR1(I) COOR1 being a hydrolysable carboxylic ester group. It also relates to a process for the preparation of the compound of formula (I) consisting in putting in contact sulfur dioxide, formaldehyde, and glycine in the presence of a R1OH alcohol, or glycinate. It also relates to the use of the compound of formula (I) for the preparation of herbicides of the glyphosate type of reaction with a phosphite or a phosphonate of formula (R2O)2 P(O) H in which (R2O)2 P is a hydrolysable phosphonic ester group, then optionally by a subsequent hydrolysis reaction.
Patent NZ-236008-A (NZ)
Title: Packaging apparatus has film roll support and film transporting device that are width adjustable
Inventor: MASAMI NAKASHIMA
IPC: B65B11/54
Filed: 1990-11-08
Abstract: A weighing-packaging-pricing apparatus has a roll supporting device (100) to rotatably support a film roll (101), a film transporting device to pull a stretch film from this film roll and to transport a stretched film sheet to a packaging station (500), a weighing device (300) for weighing and measuring the dimensions of an object on a tray to be packed while it travels to a lifter which lifts the object to the packaging station and pushes it against the stretched film sheet, a folding device for folding edge sections of the film sheet to form a package, a retractable sealing device for sealing the edge sections, a label printer (900) for printing price label and a control device (800) which controls the film transportation device such that the film is stretched when it is perforated and when it is delivered to the packaging station, operates the folding device according to the measured dimensions of the object, and automatically selects a weighing-pricing mode of operation if the sealing device is found in retracted position. Separation between units for clamping both side edge sections of the film is automatically adjusted according to the length of the film roll to provide proper tension to the film.
Patent NZ-264822-A (NZ)
Title: Substituted pyridine or pyridazine carboxamide ester derivatives, preparation and pharmaceutical compositions thereof
Inventor: WEIDMANN KLAUS
IPC: C07D217/26
Filed: 1994-10-31
Abstract: The invention relates to compounds of the formula I <IMAGE> a process for their preparation, and their use as medicaments. In particular, the compounds are employed as ester prodrugs of proline hydroxylase inhibitors for the inhibition of collagen biosynthesis, and as fibrosuppressants.
Patent NZ-289161-A (NZ)
Title: Inhaler with an optimisation chamber
Inventor: BELL JOHN H
IPC: A61M15/00
Filed: 1995-06-15
Abstract: The device comprises an actuator body 20 adapted to receive a medicament dispenser 40, and medicament delivery outlet means 23 through which medicament is delivered in an airstream in response to inhalation by a user, the outlet means being provided with an optimisation chamber 60 having a mouthpiece 61. The chamber has a volume in the range from 20 ml to 200 ml and is optionally fitted with baffle means serving to ensure that the larger droplets/particles are retained within the chamber so that only the smaller droplets pass through the oro-pharynx to enter the trachea etc. The actuator body and optimisation chamber may be engageable by a push-jet connection or may be pivotally connected to form a unitary device. <IMAGE>
Patent NZ-329891-A (NZ)
Title: Method of upgrading firmware of trusted device using embedded key
Inventor: SUDIA FRANK W
IPC: G06Q20/38
Filed: 1995-01-13
Abstract: key associated with a firmware source is embedded within the trusted device.  Firmware is communicated to the trusted device and is modified by the firmware source in a manner that can be confirmed using the embedded key.  The firmware is incorporated into the trusted device contingent upon confirmation of the communication using the embedded key.
Patent NZ-333325-A (NZ)
Title: Recombinant chimeric heteromultimer adhesins comprising extracellular domains of ErbB receptors
Inventor: FITZPATRICK VINCENT DANIAL
IPC: C07K14/71
Filed: 1997-07-08
Abstract: The application relates to chimeric heteromultimer adhesins that bind the ligand of natural heteromultimeric receptors and uses therefor.  The chimeric molecules of the heteromultimer adhesins comprise an extracellular domain of a heteromultimeric receptor monomer and a multimerization domain for the stable interaction of the chimeric molecules in the adhesin. Preferred are heteromultimeric adhesins comprising the extracellular domains of ErbB2 and ErbB3 or ErbB2 and ErbB4. The chimeric ErbB heteromultimer adhesins of the application are useful as competitive antagonists or agonists of a neuregulin for the treatment of diseases such as various cancers.
Patent NZ-334661-A (NZ)
Title: Conservatory roof construction comprises ring beam, ridge beam, valley beams and glazing bars
Inventor: RICKMAN PAUL DOUGLAS
IPC: E04D3/08
Filed: 1999-03-12
Abstract: [  Patent 334661  A conservatory roof construction comprises a ring beam 10 adapted to be laid around the upper surfaces of the conservatory walls, a ridge member 12 and a plurality of glazing bars 13 extending between ridge member 12 and ring beam 10.  Ring beam 10 comprises a channel which defines a surface for supporting the other ends of glazing bars 13.  Ridge member 12 comprises a central member 30 and a pair of channels 17 disposed one to each side of central member 30.  Ridge channels 17 define surfaces for supporting the ridge ends of glazing bars 13.  Ridge member 12 and ring beam 10 have the same channel section type.
Patent NZ-335344-A (NZ)
Title: Producing tartaric acid from potassium hydrogentartrate (KHT)
Inventor: BONSCH RUDOLF
IPC: C07C51/02
Filed: 1999-04-22
Abstract: Tartaric acid is produced from a raw material which contains yeast and at least 5 wt % potassium hydrogentartrate (KHT).   For example, yeast from wine production may be used.   In the first reaction stage the raw material is mixed with aqueous potassium hydroxide solution to form dipotassium tartrate. The yeast -containing sludge is separated by filtration, and once washed may be employed as fodder.   In a precipitation stage the solution is mixed with tartaric, sulfuric or hydrochloric acid at pH of 2 - 5.  The crystallized KHT produced is separated from the suspension, washed and heated to produce a saturated KHT solution.  This is passed through a cation exchanger to remove the K+ ions, leaving a purified aqueous tartaric acid solution.
Patent NZ-501478-A (NZ)
Title: 8,20-bis-(substituted benzyl)-desoxycyclodepsipeptides and their use for combatting endoparasites
Inventor: DYKER HUBERT
IPC: A61K31/4035
Filed: 1998-05-25
Abstract: These desoxycyclodepsipeptides have the formula (I) wherein: C=X1, C=X2, C=X3 and C=X4 are independently CO, CS or CH2 with at least one of these groups being represents CH2; R1 and R2 are independently hydrogen, alkyl, hydroxymethyl or alkoxymethyl; R3 and R4 are independently alkyl, or optionally W substituted phenyl or benzyl; W is halogen, nitro, cyano, carbonyl, alkoxycarbonyl, alkyl, -CH(R13)NR14R15, alkenyl, alkoxycarbonylalkenyl, alkynyl, alkoxycarbonylalkynyl, hydroxyl, alkoxy, alkoxyalkoxy, alkoxyalkoxyalkoxy, dialkylaminoalkoxy, or optionally substituted aryl, arylalkyl, aryloxy or arylmethoxy; or heterocyclylmethoxy, -NR16R17, -SO2-NR16R17, -SR18, -S(O)R18 or-S(O)2R18; R5, R6, R7 and R8 are independently hydrogen, optionally amino- or hydroxyl-substituted alkyl; or mercapto, methyl, methylthioethyl, carboxymethyl, carboxyethyl, carbamoylmethyl, carbamoylethyl, guanidinopropyl or optionally amino-, nitro-, halogen-, hydroxyl- or methoxy-substituted phenyl or benzyl; naphthylmethyl, indolylmethyl, imidazolylmethyl, triazolylmethyl or pyridylmethyl where functional groups may optionally be protected and R9, R10, R11 and R12 are independently hydrogen or optionally substituted alkyl. An endo parasitical composition thereof is disclosed
Patent NZ-504936-A (NZ)
Title: Simultaneous administration of polynucleotide and delayed release polypeptide encoded by the polynucleotide to enhance an immune response of nucleic acid vaccination
Inventor: DALEMANS WILFRIED L J
IPC: A61K48/00
Filed: 1998-12-11
Abstract: Described is the use of a polynucleotide encoding a polypeptide of interest for the manufacture of a pharmaceutical composition.  This composition may be used in a method to enhance an immune response by nucleic acid vaccination via simultaneous administration of a polynucleotide and the polypeptide of interest.
Patent NZ-505650-A (NZ)
Title: Pharmaceutical composition containing an antioxidant
Inventor: ASMUSSEN BODO
IPC: A61K47/14
Filed: 1999-01-08
Abstract: A pharmaceutical composition comprising (S)-N-ethyl-3-[1-dimethylamino]-N-methyl-phenyl-carbamate in free base or acid addition salt form and an anti-oxidant.
Patent NZ-509361-A (NZ)
Title: Multi-phase aqueous suspoemulsion comprising 1 to 50 % of a benzimidazole combined with an emulsion that comprises other fungicidally active ingredients, and a method for treating timber against the attack of harmful fungi
Inventor: KOBER REINER
IPC: A01N43/30
Filed: 1999-07-14
Abstract: A multi-phase suspoemulsion containing a) 1 to 50% by weight of particular fungicidal benzimidazoles or precursors liberating them as microsuspended solids particles and b) 5 to 60% by weight of an emulsion comprising a fungicidal ingredient selected from fenpropimorph, fenpropidin, tridemorph, aldimorph and spiroxamine, in combination with at least one of an azole fungicidal active ingredient or a particular benzoic ester in a water diluted form for protection of timber against fungal timber pests.
Patent NZ-511336-A (NZ)
Title: Interconnecting disengageable flooring system
Inventor: NELSON THOMAS JOHN
IPC: E04B5/00
Filed: 2001-04-26
Abstract: The invention relates to a disengageable interconnecting flooring system, for use in forming temporary or permanent laminate flooring surface on top of a support structure, on top of a support structure from individual flooring panels.  The system includes two or more flooring panels comprising a top wear surface and a bottom surface for contact with the support structure.  The panels have at least three edges and all edges have recesses formed therein. The system further comprises a connector (1) having a base (2) and a projection (3,4,5) extending vertically from the base.  The projection extending from the base is shaped to be received in a disengageable vertical connected fashion into the recesses of the panels. Preferably the connector (1) is comprised of a base (2) having a projection (3,4,5) extending the entire length thereof.  In a preferred embodiment, the connector (1) and panels further comprise means for connecting the panels in a disengageable horizontal fashion.
Patent NZ-514462-A (NZ)
Title: Reclosable container with indented lid and sealing sheet layer below lid following contour of the indent
IPC: B29C51/08
Filed: 2001-09-26
Abstract: A reclosable container (10) that comprises: a)	a container having an opening (22) defined by a rim (18); b)	a reclosable lid (32) having a rim-engaging portion (34) and a recessed portion (36) inwardly of the rim-engaging portion; and c)	sealing sheet material (38) separate from the lid, the sealing sheet material extending across the opening and becoming removable secured to the container rim beneath the lid; wherein the recessed portion of the lid (36) projects into the container opening (22) and the sealing sheet material has a recessed portion (38) which accommodates the recessed portion of the lid.  The rim of the container comprises an upper end face (28) supported at an inner edge by a wall of the container (26) and a skirt (30) depending from the upper end face.
Patent NZ-520822-A (NZ)
Title: O-aryl glucoside SGLT2 inhibitors and method
Inventor: WASHBURN WILLIAM N
IPC: A61K31/22
Filed: 2001-03-29
Abstract: Formula (I) wherein Y is formula (a) or heteroaryl; A is -O(CH2)m, S, -NH(CH2)m, or (CH2)n where n is 0-3 and m is 0-2; and R1 to R6 are as defined herein. A method is also provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the above compound alone or in combination with one, two or more other antidiabetic agents, and/or one, two or more hypolipidemic agents.
Patent NZ-525453-A (NZ)
Title: Near  infrared fluorescent contrast agent  useful  for fluorescence imaging of tumour or in angiography
Inventor: MIWA NAOTO
IPC: A61K49/00
Filed: 2003-04-23
Abstract: A near infrared fluorescent contrast agent comprising a sodium  salt  of the formula shown herein, and a  method  of fluorescence   imaging  comprising  introducing   the   near infrared   fluorescent  contrast  agent  of  the   described formula  into  a  living  body,  exposing  the  body  to  an excitation  light, and detecting near infrared  fluorescence from the contrast agent is disclosed. The   near  infrared  fluorescent  contrast  agent  of   the described  formula  is  excited by an excitation  light  and emits    near    infrared   fluorescence.   This    infrared fluorescence is superior in transmission through  biological tissues.  Thus, detection of lesions in the deep part  of  a living  body  has  been  made possible.  In  addition,  this infrared  fluorescent contrast agent is  superior  in  water solubility  and  low toxic, and therefore, it  can  be  used safely for tumour imaging and for angiography.
Patent NZ-527137-A (NZ)
Title: Boss and shutter assembly
Inventor: GRIFFITHS ROBERT PHILLIP
IPC: E06B7/096
Filed: 2001-12-21
Abstract: A boss (30) for use in a shutter having blades, the boss including an axial pin about which the boss is adapted to rotate, a complementary surface adapted to engage a translating member such as a toothed rack, a bearing surface adapted to rest in or on a support in the shutter assembly and blade engaging means (48). A shutter assembly and blade configuration are also disclosed.